查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197048

黄金纳米颗粒市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Gold Nanoparticles Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，全球金纳米粒子市场预计将以超过 10% 的复合年增长率增长。

COVID-19 对最近调查的市场产生了负面影响。 电子行业是金纳米粒子的主要消费者，受到疫情的严重影响。 与 2019 年相比，2020 年全球电子产品出货量下降了 337 万台。 由于限制和封锁，许多进出口已暂停一段时间。 由于旅行限制和社会疏远协议，更多的项目和工厂被暂停。 随着市场开放和大多数国家的封锁解除，未来几年对于金纳米粒子市场来说将是一个令人鼓舞的迹象。

主要亮点

  • 从中期来看，纳米技术在医疗行业应用的扩展和高端电子行业需求的增加是推动市场发展的主要因素。
  • 另一方面，金价波动预计会阻碍市场增长。
  • 在预测期内，电子行业的技术创新可能会为市场带来机遇。
  • 预计北美地区将主导全球纳米粒子市场，预计北美地区在整个预测期内增长最快。

金纳米粒子市场趋势

靶向给药主导市场

  • 靶向给药领域是金纳米粒子市场最大的应用基础之一。
  • 靶向药物递送系统是指通过纳米颗粒将药物或药理活性剂□□选择性地递送至精确的相应作用或吸收位点，而不是递送至非靶器官、组织或细胞的药物。它是一种先进的形式输送系统。
  • 将纳米粒子引入靶向药物递送系统带来了各种优势，包括高治疗效果、高靶向效率和可重复性。
  • 金纳米粒子用于将多种药物分子、疫苗、重组蛋白或核甘酸递送至目标，控制通过生物刺激（内部）或光激活（外部）释放的药物量。这也是可能的。
  • 2019 年，美国的医疗保健支出从 2018 年的 4838 亿美元增长近 4% 至约 5110 亿美元。 人口老龄化和个人健康风险的增加预计只会推动靶向药物输送，从而推动该领域的金纳米颗粒市场。
  • 金纳米粒子的其他应用之一是可以使用一些特殊聚合物（例如聚乙二醇 (PEG)）对其表面进行修饰。 这有望提高金纳米粒子在不同生理条件下的稳定性，并实现金纳米粒子的不同组合。 预计这将进一步增加金纳米粒子在药物输送应用中的使用。
  • 因此，预计上述所有因素都将在未来几年推动所研究市场的需求。

北美主导市场

  • 在预测期内，预计北美地区将主导全球金纳米粒子市场。
  • 美国的医疗技术是该地区最重要和最具活力的行业之一，并且继续成为推动医疗保健系统变革的推动力。
  • 美国是世界领先的医疗保健行业之一，美国医疗保健支出占该国 GDP 的 17%，2019 年达到 3.8 万亿美元，较 2018 年同比增长。增长 4.6%。 预计这种增长将在未来几年继续。
  • 该国的医疗技术在世界上名列前茅，并提供尖端的救生和维持生命的产品。 在大量研发投资的推动下，该国的医疗技术在所有相关指标上都树立了标准，包括增长、就业趋势、产出、出口、全球市场份额和风险资本融资。
  • 通常，大约 35% 到 40% 的国内医疗器械产量用于出口，而美国国内消费量中有类似比例是进口的。 国际销售额，包括来自海外子公司的销售额，约占美国医疗器械公司总销售额的 40% 至 50%。
  • 美国的医院每年在医疗设备生命週期服务成本上花费大约 930 亿美元。
  • 设备小型化和纳米技术等领域的突破为美国金纳米颗粒市场的发展提供了巨大机遇。
  • 此外，电子行业的技术进步和研发活动的快速创新对更新更快的电子产品提出了很高的需求。 在美国，专注于高端产品的製造工厂和开发中心数量激增，预计这将在预测期内提振对金纳米粒子的需求。
  • 由于加拿大人重视新产品创新，加拿大消费电子行业在关键产品类别中取得了增长并抓住了新机遇。 推动该行业增长的一个因素是该国改善的网络连接。
  • 因此，由于上述因素，预计该地区的金纳米粒子市场在预测期内将呈现高速增长。

金纳米颗粒市场竞争者分析

金纳米颗粒市场具有部分整合的性质。 所研究市场的主要参与者包括 Merck KGaA、BBI Solutions、Tanaka Holdings、Nanocomposix 和 Cytodiagnostics Inc 等公司。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 调查结果
  • 调查假设
  • 本次调查的范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 司机
    • 扩大纳米技术在医疗行业的应用
    • 高端电子领域的需求增加
  • 约束因素
    • 金价波动
    • COVID-19 造成的不利情况
  • 工业价值链分析
  • 波特的五力分析
    • 供应商的议价能力
    • 消费者的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争程度

第 5 章市场细分

  • 申请
    • 成像
    • 靶向给药
    • 传感器
    • 体外诊断
    • 调查
    • 催化
    • 其他用途
  • 最终用户行业
    • 电子产品
    • 医疗保健
    • 化学
    • 其他最终用户行业
  • 按地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 意大利
      • 法国
      • 其他欧洲地区
    • 世界其他地区
      • 南美洲
      • 中东

第六章竞争格局

  • 併购、合资企业、联盟、合同
  • 市场份额 (%)**/排名分析
  • 主要参与者的策略
  • 公司简介
    • Aurion
    • BBI Solutions
    • Cline Scientific AB
    • Cytodiagnostics Inc.
    • Sona Nanotech.
    • Meliorum Technologies Inc.
    • Merck KGaA
    • nanoComposix
    • NanoHybrids
    • NANOPARTZ INC.
    • TANAKA HOLDINGS Co., Ltd.

第七章市场机会与未来趋势

  • 电子领域的创新
  • 其他商业机会
简介目录
Product Code: 64912

The Global Gold Nanoparticles market is expected to witness a CAGR of greater than 10% during the forecast period.

COVID-19 has negatively affected the market studied in receny times. The electronics industry which is a major consumer of gold nanoparticles was severely impacted by t he pandemic. The global electronics shipments have fallen by 3.37 million units in 2020 compared to 2019. Due to the restrictions and the lockdown, many imports and exports were halted for a specified period. Further a lot of projects and plants were paused due to travel restrictions and social distancing protocols. Since the markets are opening, and the lockdowns being lifted in most of the countries, it will be an encouraging sign for the gold nano-particles market in coming years.

Key Highlights

  • Over the mid-term, the major factors driving the market studied are rising nanotechnology applications in the medical industry and rising demand from the high-end electronics sector.
  • On the flipside, volatility in the price of gold is expected to hinder the growth of the market studied.
  • Innovation in the field of electronics is likely to act as an opportunity for the market studied during the forecast period.
  • North America region is expected to dominate the global nanoparticles market; while North America is expected to register the fastest growth through the forecast period.

Gold Nanoparticles Market Trends

Targeted Drug Delivery to Dominate the Market

  • The targeted drug delivery segment represents one of the largest application bases for the gold nanoparticles market.
  • Target drug delivery system is an advanced form of drug delivery system where the medication drug or a pharmacologically active agent is selectively delivered by the nanoparticles at an exact corresponding site of action or absorption, and not to the non-target organs, tissues, or cells.
  • The introduction of nanoparticles to the targeted drug delivery system has resulted in various benefits, such as high therapeutic efficacy, high targeting efficiency, and reproducibility.
  • Gold nanoparticles are used to deliver multiple drug molecules, vaccines, recombinant proteins, or nucleotides into their targets, and can also control the volume of drug released via biological stimuli (internal) or light activation (external).
  • In the United States in the year 2019, the amount spent on medicine was around USD 511 billion increasing by nearly 4% from USD 483.8 billion in 2018. Rising old age population and increasing health risk amongst individuals is only expected to drive the market for targeted drug deliveries and hence gold nanoparticles from this sector.
  • One of the other use of gold nanoparticles is that its surface can be modified using some specialty polymers, like polyethylene glycol (PEG). This is expected to result in increased stability of gold nanoparticles in different physiological conditions and also to provide a multiformity of combinations on gold nanoparticles. This is further expected to boost the usage of gold nanoparticles in treated drug delivery applications.
  • Therefore, all the above mentioned factors are expected to drive the demand for the market studied in coming years.

North America to Dominate the Market

  • North America region is expected to dominate the global gold nanopertocles market during the forecast period.
  • The medical technology of the United States continues to be one of the most vital and dynamic sectors of the region and a leading force in the revolution that is transforming the health care system.
  • The United States is a leading healthcare industry in the world, the expenditure on healthcare in United States accounted to 17% of its national GDP and reached a value of USD 3.8 trillion in 2019, a y-o-y growth of 4.6% from 2018. The growth is expected to continue further through the upcoming years too.
  • The medical technology of the country is one of the best globally and offers state-of-the-art life-saving and life-enhancing products. Fueled by huge research and development investments, the medical technology of the country set a standard on all relevant measures of growth, employment trends, production values, exports, global market share, venture capital financing.
  • Adiitionally, apprximately 35% -40% of the total domestic medical device production is exported, and a similar share of the United States' domestic consumption is imported. Overseas sales account for approximately 40% - 50% of the overall revenues for United States medical device companies, including the foreign subsidiaries' revenue.
  • The American Hospitals Annually spend around USD 93 billion per year on service on the Medical devices lifecycle cost.
  • The breakthroughs in areas, such as device miniaturization and nanotechnology, have created vast opportunities for the growth of the gold nanoparticles market in the United States.
  • Furthermore, owing to the rapid pace of innovation in the advancement of technology and R&D activities in the electronics industry, there is a high demand for newer and faster electronic products. There is a spur in the number of manufacturing plants and development centers in the United States that are focusing on high-end products, which is expected to boost the demand for gold nanoparticles over the forecast period.
  • Canadian consumer electronics industry experienced growth and grabbed new opportunities in the key product category, as Canadians value new product innovations. The factor driving the growth of this industry is the improved network connectivity in the country.
  • Hence, due to the aforementioned factors, the market for gold nanoparticles in the region is expected to witness high growth over the forecast period.

Gold Nanoparticles Market Competitor Analysis

The gold nanoparticles market is partially consolidated in nature. The major companies of the market studied include Merck KGaA, BBI Solutions, Tanaka Holdings Co Ltd., Nanocomposix, and Cytodiagnostics Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Rising Nanotechnology Applications in the Medical Industry
    • 4.1.2 Rising Demand from the High-end Electronics Sector
  • 4.2 Restraints
    • 4.2.1 Volatility in Price of Gold
    • 4.2.2 Unfavorable Conditions Arising due to the Impact of COVID-19
  • 4.3 Industry Value-Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION

  • 5.1 Application
    • 5.1.1 Imaging
    • 5.1.2 Targeted Drug Delivery
    • 5.1.3 Sensors
    • 5.1.4 In Vitro Diagnostics
    • 5.1.5 Probes
    • 5.1.6 Catalysis
    • 5.1.7 Other Applications
  • 5.2 End-user Industry
    • 5.2.1 Electronics
    • 5.2.2 Healthcare
    • 5.2.3 Chemicals
    • 5.2.4 Other End-user Industries
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 South Korea
      • 5.3.1.5 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 Italy
      • 5.3.3.4 France
      • 5.3.3.5 Rest of Europe
    • 5.3.4 Rest of the World
      • 5.3.4.1 South America
      • 5.3.4.2 Middle-East

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share (%)**/ Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Aurion
    • 6.4.2 BBI Solutions
    • 6.4.3 Cline Scientific AB
    • 6.4.4 Cytodiagnostics Inc.
    • 6.4.5 Sona Nanotech.
    • 6.4.6 Meliorum Technologies Inc.
    • 6.4.7 Merck KGaA
    • 6.4.8 nanoComposix
    • 6.4.9 NanoHybrids
    • 6.4.10 NANOPARTZ INC.
    • 6.4.11 TANAKA HOLDINGS Co., Ltd.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Innovation in the Field of Electronics
  • 7.2 Other Opportunities